Spero Therapeutics is trading at $1.29 (+7.6%) in after-hours following a technical rebound from recent weakness.

  • No new company-specific headlines, earnings, or FDA updates were released today to drive the price action.
  • The move appears tied to thin after-hours liquidity and a broader risk-on market tone rather than a fresh fundamental catalyst.